The adjuvant endocrine treatment revolution: focus on anastrozole

Author： Jakesz Raimund  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.2, Iss.2, 2006-04, pp. : 301-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 564-574

Bentham Science Publishers

Access to resources Recommend Favorite

TAnDEM treatment with trastuzumab plus anastrozole on top

By  

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Anastrozole efficacy extends beyond treatment completion

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Effects of anastrozole outlast treatment in HR+ breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Adjuvant treatment for renal cell carcinoma

By Lam John S   Belldegrun Arie S   Figlin Robert A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 705-720

Informa Healthcare

Access to resources Recommend Favorite